Back to search

Article

The Impact of CYP2C19 Genotype on Clopidogrel Response and Clinical Outcomes in Coronary Artery Disease Patients: A Correlation with SYNTAX Score

2025-08-06

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> CYP2C19 polymorphism helps determine the reactivity of platelets in coronary artery disease. The impact of CYP2C19 genotype on clopidogrel response and clinical outcomes remains unclear. The SYNTAX score helps in determining the prognosis. <h4>Methods</h4> To test this, we enrolled more than 500 patients with ischemic heart disease. All the patients were on follow-up treatm...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b2ff4e80-8148-56ce-952a-726c0a0a1914
DOI
10.1101/2025.08.04.25332994
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Impact of CYP2C19 Genotype on Clopidogrel Response and Clinical Outcomes in Coronary Artery Disease Patients: A Correlation with SYNTAX ScoreDOI 10.1101/2025.08.04.25332994
Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study.Semantic proximity
Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention.Semantic proximity
A real-world study of clopidogrel therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention guided by individualized metabolic typesSemantic proximity
The efficacy and safety of CYP2C19 genotype-guided antiplatelet therapy compared with conventional antiplatelet therapy in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.Semantic proximity
The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD).Semantic proximity
Effects of individualized antiplatelet therapy based on CYP2C19 genotype and platelet function on the prognosis of patients after PCI.Semantic proximity
Adverse events in cardiovascular disease patients taking clopidogrel: impact of CYP2C19 genotype polymorphismsSemantic proximity
[Effects of clopidogrel resistence and CYP2C19 genotype on the clinical prognosis of patients with acute coronary syndrome undergoing percutaneous coronary intervention].Semantic proximity
Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention.Semantic proximity
Incidence of major adverse cardiovascular events with genotype test guided antiplatelet treatment strategy after percutaneous coronary intervention.Semantic proximity
[Impact of CYP2C19 genotype and platelet function on clinical outcome in coronary atherosclerotic heart diseases patients received clopidogrel post percutaneous coronary intervention].Semantic proximity
The Cytochrome P450 2C19 Polymorphism Associated with Major Adverse Cardiovascular Events Risk in Kazak Patients Undergoing Percutaneous Coronary Intervention and Receiving Clopidogrel.Semantic proximity
Select a neighboring publication to make it the new centre.